Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
<20 |
20-39 |
>39 |
Base (known status) |
|---|---|---|---|---|
Czech Republic |
1.7 |
2.6 |
2.7 |
1181 |
Denmark |
2.3 |
3.4 |
3.0 |
1390 |
Germany |
3.5 |
5.4 |
2.2 |
16274 |
Greece |
2.6 |
7.1 |
8.4 |
1288 |
Italy |
3.7 |
7.5 |
7.4 |
36259 |
Cyprus |
3.0 |
10.5 |
|
169 |
Latvia |
2.0 |
5.4 |
1.2 |
277 |
Luxembourg |
0.8 |
|
|
29 |
Hungary |
2.8 |
5.0 |
0.6 |
4810 |
Malta |
4.0 |
5.1 |
|
306 |
Netherlands |
3.5 |
4.0 |
2.4 |
4884 |
Slovakia |
3.8 |
5.0 |
0.5 |
363 |
Slovenia |
2.1 |
3.6 |
2.3 |
551 |
Finland |
1.7 |
2.2 |
1.1 |
636 |
Sweden |
1.9 |
2.3 |
0.9 |
967 |
United Kingdom |
2.0 |
2.6 |
2.7 |
31247 |
Bulgaria |
1.7 |
5.6 |
|
504 |
|
|
|
|
|
Total |
2.7 |
4.5 |
3.6 |
101135 |
Notes: The table is left blank where there are no female cases. See also 'General notes for interpreting data' on the Explanatory notes and help page. Source: 2005 Reitox national reports - TDI outpatient treatment centres | ||||